Changing the
Game in Mental
Health Treatment
At the forefront of a public health crisis,
mental illness defines our era. In America alone, depression and anxiety disorders are not just prevalent, but escalating rapidly, especially among youth. Despite this, effective treatments are either inaccessible or inadequate for many. Half of those with a diagnosable mental illness do not seek treatment, and for those who do, the results are often unsatisfactory. This grim reality reflects the shortcomings of our current standard of care.
Enter the world of digital
therapeutics (DTx)
Pioneering a new era of mental healthcare, DTx is a new category of evidence-backed, app-based treatments that promise to improve the existing standard of care with less risks and more accessibility. This innovative new approach to treatment is gaining momentum, with stakeholders across the healthcare spectrum advocating for its integration into mainstream treatment.
A unique intersection of neuroscience, psychology,
and gaming
At Arcade, we’ve embraced a unique intersection of neuroscience, psychology, and gaming to develop game-based digital therapies. Our core intervention, attention bias modification (ABM), targets unconscious mindsets and cognitive biases that contribute to mental illness. Our approach has shown promising results in addressing conditions like anxiety, depression, and addiction.
Committed to creating engaging, stigma-free treatments
Our journey is marked by rigorous scientific validation and a commitment to creating engaging, stigma-free treatment options. With FDA discussions and clinical trials underway, we’re poised to revolutionize mental healthcare. Our vision extends beyond treatment to include partnerships with health systems and insurers, aiming to make our digital therapeutics accessible to those in dire need.
We invite you to explore the possibilities with us on this transformative journey. Join us in redefining mental healthcare for the digital age.
Leadership
Raj Amin
CO-FOUNDER & CEO
Raj is a tech entrepreneur with extensive experience building new products and companies that scale with positive impact. He has co-founded 3 venture-backed companies, and led product innovation initiatives for global Fortune 100 companies in healthcare, online media, entertainment, and transportation. He has designed or launched products at companies including Ericsson, Avis Budget Group, Roche, Hospital for Special Surgery, Sony Music, the City of Los Angeles, and a number of startups.
Tracy Dennis-Tiwary, PhD
CO-FOUNDER & CHIEF SCIENCE OFFICER
Dr. Tracy Dennis-Tiwary is a pioneer in the science of digital therapeutics. She has 20+ years of clinical and neuroscience research experience and is a leading expert on the anxious brain, one of the few translating her work into clinically validated digital therapeutics. She has conducted decades of NIH-funded research, with over 100 peer-reviewed publications. Dr. Dennis-Tiwary has been widely featured throughout the media, including The New York Times, Wall Street Journal, Washington Post, NPR, ABC, MSNBC, and many more. She is the author of the bestselling book Future Tense: Why Anxiety Is Good for You (Even Though It Feels Bad).
Arcade is on a mission to transform how we access, engage, and deliver mental health treatment through novel therapeutic approaches that lower barriers to care.
Industry advisors
Tim Juergens
SeedLink SL Partner
20 year executive within Roche Diabetes Care
Melindah Sharma
Co-founder of VLab Partners
Formerly Johnson & Johnson, 25+ years defining corporate strategy, operations and portfolio management
Noah Falstein
World class game developer and designer
Formerly LucasArts, The 3DO Company, Dreamworks Interactive, IGDA, Chief Game Designer at Google
Recognized expert on games for health
Alex Apollonsky
Director of Data Architecture, Comcast
Mana Health Chief Technology Officer (‘14-’18)
Nina Thomas
Vice President, Ultragenyx Pharmaceuticals
Formerly Genentech, Bristol Myers Squibb, Eli Lilly, Bayer
Rob Rebak
4x CEO of industry-leading, high-growth healthtech companies
Nayan Ghosh
Marwood Group Head of Life Sciences & HealthTech
Formerly Arcade Therapeutics Head Of Commercial & Regulatory Strategy
Leigh Charvet, PhD
Director of Multiple Sclerosis Research, NYU Langone Medical Center
Formerly Johnson & Johnson, Stony Brook Medicine
Our Investors
Latest news
HealthTech 250: The Most Promising Early-stage Digital Health Ventures in 2023
Galen Growth
January 3, 2024
Sixth Annual Tech for Global Good Recognizes Arcade Therapeutics as Innovative Organization…
The Tech Interactive
November 1, 2023
This startup’s mobile game zaps anxiety disorders
Crain’s New York Business
February 15, 2023
Gaming for Mental Health: Arcade Therapeutics Combines Cutting-Edge Neuroscience with Mobile Games
Startup Health
November 27, 2023
